We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

(THE CONVERSATION) The 2024 Nobel Prize in physiology or medicine goes to Victor Ambros and Gary Ruvkun for their discovery of microRNA, tiny biological molecules that tell the cells in your body what ...

A Practice for Everyday Life (APFEL) has created a new identity for Lisbon’s Centro de Arte Moderna (CAM), inspired by the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream.

The global digital dentures market is projected to grow from USD 1.42 billion in 2024 to USD 2.16 billion by 2029, reflecting ...

GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...

(NASDAQ: CAKE) offers upscale dining experiences in its flagship locations with an extensive menu known for its large portion sizes and signature desserts. It also owns and operates many smaller ...

Moderna Inc. closed $112.18 short of its 52-week high ($170.47), which the company achieved on May 24th.

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...